Recombinant SeV-hFGF2/dF Injection for PAOD

Clinical trial NCT03668353 · UNKNOWN

Trial details

NCT number: NCT03668353
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

PAOD - Peripheral Arterial Occlusive Disease PAD Critical Limb Ischemia

Start date: 2018-09-05
Primary completion: 2020-03-05
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.